CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Study of Niraparib for Leiomyosarcoma With Alterations in the Homologous Recombination DNA Repair Pathway

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05174455
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:34.730815+00:00
Published At: 2023-09-18T00:00:00+00:00
Record Updated At: 2023-09-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Locally Advanced Leiomyosarcoma", "Metastatic Leiomyosarcoma", "Stage III Retroperitoneal Sarcoma AJCC v8", "Stage IIIA Retroperitoneal Sarcoma AJCC v8", "Stage IIIB Retroperitoneal Sarcoma AJCC v8", "Stage IV Retroperitoneal Sarcoma AJCC v8", "Unresectable Leiomyosarcoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-09-18"
protocolSection.identificationModule.nctId: "NCT05174455"
protocolSection.identificationModule.officialTitle: "Phase II Study of Niraparib for Leiomyosarcoma With Alterations in the Homologous Recombination DNA Repair Pathway"
protocolSection.statusModule.overallStatus: "WITHDRAWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.